Authors

• Diego Alvarado (ORCID: https://orcid.org/0000-0002-5878-1730)
• Elizabeth Crowley
• John Anderson (ORCID: https://orcid.org/0000-0003-3578-8064)
• Martin Metz (ORCID: https://orcid.org/0000-0002-4070-9976)
• Elsa Paradise
• Neetu Talreja (ORCID: https://orcid.org/0000-0003-4891-0575)
• Jonathan A. Bernstein (ORCID: https://orcid.org/0000-0002-3476-1196)
• Marcus Maurer (ORCID: https://orcid.org/0000-0002-4121-481X)
• Diane Young
• Thomas Hawthorne
• Margo Heath‐Chiozzi
• Rick Ma

Institutions

• University of Alabama (US)
• Fraunhofer Institute for Translational Medicine and Pharmacology (DE)
• Birmingham VA Medical Center (US)
• Celldex Therapeutics (United States) (US)
• University of Cincinnati (US)
• Charité - Universitätsmedizin Berlin (DE)

Publication Details

Journal

Allergy

Published

2025-05-26

DOI

https://doi.org/10.1111/all.16598

Citations

19

Primary Topic

Urticaria and Related Conditions

Type

article

Field-Weighted Citation Impact

31.69

Funders

• Amgen
• Eli Lilly and Company
• Pfizer
• AstraZeneca
• GlaxoSmithKline
• Sanofi
• Teva Pharmaceutical Industries
• CSL Behring
• Regeneron Pharmaceuticals
• Celldex Therapeutics
• BioCryst
• Allergy Therapeutics
• Incyte
• Celltrion
• Argenx
• Galderma
• Genentech
• Pearl Therapeutics